131 related articles for article (PubMed ID: 35058229)
1. EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
Courvoisier DS; Lauper K; Kedra J; de Wit M; Fautrel B; Frisell T; Hyrich KL; Iannone F; Machado PM; Ørnbjerg LM; Rotar Z; Santos MJ; Stamm TA; Stones SR; Strangfeld A; Bergstra SA; Landewé RBM; Finckh A
Ann Rheum Dis; 2022 Jun; 81(6):780-785. PubMed ID: 35058229
[TBL] [Abstract][Full Text] [Related]
2. Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology.
Lauper K; Kedra J; de Wit M; Fautrel B; Frisell T; Hyrich KL; Iannone F; Machado PM; Ørnbjerg LM; Rotar Z; Santos MJ; Stamm TA; Stones SR; Strangfeld A; Landewé RB; Finckh A; Bergstra SA; Courvoisier DS
RMD Open; 2021 Nov; 7(3):. PubMed ID: 34789534
[TBL] [Abstract][Full Text] [Related]
3. EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.
Boonen A; Putrik P; Marques ML; Alunno A; Abasolo L; Beaton D; Betteridge N; Bjørk M; Boers M; Boteva B; Fautrel B; Guillemin F; Mateus EF; Nikiphorou E; Péntek M; Pimentel Santos F; Severens JL; Verstappen SMM; Walker-Bone K; Wallman JK; Ter Wee MM; Westhovens R; Ramiro S
Ann Rheum Dis; 2021 Sep; 80(9):1116-1123. PubMed ID: 33832966
[TBL] [Abstract][Full Text] [Related]
4. EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.
Dejaco C; Putrik P; Unger J; Aletaha D; Bianchi G; Bijlsma JW; Boonen A; Cikes N; Finckh A; Gossec L; Kvien TK; Madruga Dias J; Matteson EL; Sivera F; Stamm TA; Szekanecz Z; Wiek D; Zink A; Ramiro S; Buttgereit F
RMD Open; 2018; 4(2):e000780. PubMed ID: 30714579
[TBL] [Abstract][Full Text] [Related]
5. 2019 EULAR points to consider for the assessment of competences in rheumatology specialty training.
Sivera F; Alunno A; Najm A; Avcin T; Baraliakos X; Bijlsma JW; Badreh S; Burmester G; Cikes N; Da Silva JA; Damjanov N; Dougados M; Dudler J; Edwards CJ; Iagnocco A; Lioté F; Nikiphorou E; van Onna M; Stones SR; Vassilopoulos D; Haines C; Ramiro S
Ann Rheum Dis; 2021 Jan; 80(1):65-70. PubMed ID: 32788400
[TBL] [Abstract][Full Text] [Related]
6. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Rönnblom L; Versnel MA; Vital EM
Ann Rheum Dis; 2023 Jun; 82(6):754-762. PubMed ID: 36858821
[TBL] [Abstract][Full Text] [Related]
7. EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs).
Dejaco C; Machado PM; Carubbi F; Bosch P; Terslev L; Tamborrini G; Sconfienza LM; Scirè CA; Ruetten S; van Rompay J; Proft F; Pitzalis C; Obradov M; Moe RH; Mascarenhas VV; Malattia C; Klauser AS; Kent A; Jans L; Hartung W; Hammer HB; Duftner C; Balint PV; Alunno A; Baraliakos X
Ann Rheum Dis; 2022 Jun; 81(6):760-767. PubMed ID: 34893469
[TBL] [Abstract][Full Text] [Related]
8. Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology.
Buch MH; Silva-Fernandez L; Carmona L; Aletaha D; Christensen R; Combe B; Emery P; Ferraccioli G; Guillemin F; Kvien TK; Landewe R; Pavelka K; Saag K; Smolen JS; Symmons D; van der Heijde D; Welling J; Wells G; Westhovens R; Zink A; Boers M;
Ann Rheum Dis; 2015 Jun; 74(6):963-9. PubMed ID: 24827533
[TBL] [Abstract][Full Text] [Related]
9. Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report--Part II.
Cox E; Martin BC; Van Staa T; Garbe E; Siebert U; Johnson ML
Value Health; 2009; 12(8):1053-61. PubMed ID: 19744292
[TBL] [Abstract][Full Text] [Related]
10. EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology.
Najm A; Costantino F; Alivernini S; Alunno A; Bianchi E; Bignall J; Boyce B; Cañete JD; Carubbi F; Durez P; Fonseca JE; Just SA; Largo R; Manzo A; Maybury M; Naredo E; Orr C; Pitzalis C; Rivellese F; Romão VC; van Rompay J; Tas SW; Veale DJ; D'Agostino MA; Filer A
Ann Rheum Dis; 2022 Dec; 81(12):1640-1646. PubMed ID: 35210263
[TBL] [Abstract][Full Text] [Related]
11. Impact of synovial biopsy procedures and disease-specific aspects on synovial tissue outcome: a systematic literature review informing the EULAR points to consider for the minimal reporting requirements in synovial tissue research in rheumatology.
Najm A; Costantino F; Weill C; Filer A; D'Agostino MA
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35177556
[TBL] [Abstract][Full Text] [Related]
12. Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group.
Santiago T; Santos EJF; Ruaro B; Lepri G; Green L; Wildt M; Watanabe S; Lescoat A; Hesselstrand R; Del Galdo F; Pauling JD; Reeve LJ; D'Agostino MA; Matucci-Cerinic M; Iagnocco A; da Silva JAP
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35850975
[TBL] [Abstract][Full Text] [Related]
13. EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update.
de Wit M; Aouad K; Elhai M; Benavent D; Bertheussen H; Blackburn S; Böhm P; Duarte C; Falahee M; Karlfeldt S; Kiltz U; Mateus EF; Richards DP; Rodríguez-Carrio J; Sagen J; Shumnalieva R; Stones SR; Tas SW; Tillett W; Vieira A; Wilhelmer TC; Zabalan C; Primdahl J; Studenic P; Gossec L
Ann Rheum Dis; 2024 Jun; ():. PubMed ID: 38876509
[TBL] [Abstract][Full Text] [Related]
14. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.
Gossec L; Kedra J; Servy H; Pandit A; Stones S; Berenbaum F; Finckh A; Baraliakos X; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Burmester GR; Radstake TRDJ
Ann Rheum Dis; 2020 Jan; 79(1):69-76. PubMed ID: 31229952
[TBL] [Abstract][Full Text] [Related]
15. Points to consider: EULAR-UEMS standards for the training of European rheumatologists.
Alunno A; Avcin T; Haines C; Ramiro S; Sivera F; Badreh S; Baraliakos X; Bijlsma JWJ; Buttgereit F; Chaudhuri K; Da Silva JAP; Dudler J; Ferreira RJO; Gudu T; Hachulla E; Holland-Fischer M; Iagnocco A; Kragstrup TW; Nagy G; Romão VC; Stones SR; van Onna M; Edwards CJ
Ann Rheum Dis; 2023 Aug; 82(8):1107-1113. PubMed ID: 37188497
[TBL] [Abstract][Full Text] [Related]
16. EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology.
Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J
Ann Rheum Dis; 2010 Sep; 69(9):1596-602. PubMed ID: 20525843
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report.
Berger ML; Dreyer N; Anderson F; Towse A; Sedrakyan A; Normand SL
Value Health; 2012; 15(2):217-30. PubMed ID: 22433752
[TBL] [Abstract][Full Text] [Related]
18. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
Bech B; Primdahl J; van Tubergen A; Voshaar M; Zangi HA; Barbosa L; Boström C; Boteva B; Carubbi F; Fayet F; Ferreira RJO; Hoeper K; Kocher A; Kukkurainen ML; Lion V; Minnock P; Moretti A; Ndosi M; Pavic Nikolic M; Schirmer M; Smucrova H; de la Torre-Aboki J; Waite-Jones J; van Eijk-Hustings Y
Ann Rheum Dis; 2020 Jan; 79(1):61-68. PubMed ID: 31300458
[TBL] [Abstract][Full Text] [Related]
19. EULAR recommendations for a core data set for pregnancy registries in rheumatology.
Meissner Y; Fischer-Betz R; Andreoli L; Costedoat-Chalumeau N; De Cock D; Dolhain RJEM; Forger F; Goll D; Molto A; Nelson-Piercy C; Özdemir R; Raio L; Rodríguez-García SC; Sciascia S; Wallenius M; Zbinden A; Zink A; Strangfeld A
Ann Rheum Dis; 2021 Jan; 80(1):49-56. PubMed ID: 33055080
[TBL] [Abstract][Full Text] [Related]
20. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
